Studies in the library show small gains on cognitive test scores from computerised brain training, but none of the records cited here shows that training or supplements prevent a dementia diagnosis. Observational data link omega-3 intake to a lower risk of dementia or cognitive decline by about 20%, yet a randomized trial of DHA in people with mild to moderate Alzheimer's found no slowing of decline.
What the studies found
For cognitively healthy people in late life, a 2020 Cochrane review of computerised cognitive training of 12 or more weeks identified eight RCTs with a total of 1183 participants. The studies had moderate risk of bias and the overall quality of evidence was low or very low for all outcomes. Results suggested slight improvement in global cognitive function at 12 weeks (SMD -0.31, 95% CI -0.57 to -0.05; 232 participants; 2 studies), and little or no difference in episodic memory or working memory; the reviewers found no evidence on quality of life, activities of daily living, or adverse effects.
For people who already have mild cognitive impairment, a 2022 systematic review and meta-analysis of 18 studies with 1059 participants found that computerised cognitive training provided a significant but small increase in global cognitive function compared with control groups (standardized mean difference=0.54, 95% CI 0.35-0.73).
A 2024 remote online randomized trial (START) compared a 3-minute computerized training program with placebo in 6544 people older than 50, taking part from home. The program conferred benefit on executive function, attention, memory and a composite measure, including in people with the ApoE4 genotype; the primary outcome was a test of executive function (Trailmaking B).
For omega-3 supplements, a 2023 analysis in the American Journal of Clinical Nutrition combined an observational cohort with a meta-analysis. In the ADNI cohort (1135 participants without dementia, mean age 73 years), long-term users of omega-3 supplements had a 64% reduced risk of Alzheimer's (hazard ratio 0.36, 95% CI 0.18-0.72) over 6 years. A meta-analysis of 48 longitudinal studies involving 103,651 participants suggested that dietary intake of omega-3 could lower the risk of all-cause dementia or cognitive decline by about 20% (DHA intake RR 0.82).
A randomized trial gives a different answer for treatment. In a 2010 JAMA trial, 402 people with mild to moderate Alzheimer's were randomized to DHA or placebo; the CDR sum of boxes score increased by 2.87 points for the DHA group during 18 months compared with 2.93 points for the placebo group (P = .68), and the authors concluded that DHA did not slow the rate of cognitive and functional decline.
- Study
- Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
A 2023 systematic review of previous reviews in Nutrition Reviews covered 20 reviews, which reported on 43 randomized controlled trials and 1 cohort study addressing 18 nutritional interventions in people with MCI. Most reviews were limited by quality and the small number of primary studies with small sample sizes; reviews were mostly positive for B vitamins, omega-3 fatty acids and probiotics, and the authors concluded that few nutritional interventions were found to convincingly improve cognition in MCI.
What remains uncertain
The training studies above report cognitive test scores, not whether people later developed dementia. The Cochrane reviewers found no evidence on quality of life or activities of daily living, so it is not known whether better scores on a trained task carry over to everyday life.
- Studies
- Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life
- Impact of Short-Term Computerized Cognitive Training on Cognition in Older Adults With and Without Genetic Risk of Alzheimer's Disease: Outcomes From the START Randomized Controlled Trial
Observational and trial results on omega-3 point in different directions. The record of the 2023 analysis lists its own limits: observational data with moderate heterogeneity, supplement users who may differ in health behaviours, and randomised supplement trials that have generally been less positive. The DHA trial tested people who already had Alzheimer's, so it does not answer whether supplements taken earlier in life change risk.
- Studies
- The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers
- Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
Many of the trials were small or short, and the 2023 review of reviews says better-quality research is needed in people with MCI. Whether any supplement or program is worth trying is a question for a clinician who knows the person's health and medicines.
This page describes what published studies in alzhub's library report. It is not medical advice and does not apply to any one person. Where a decision would follow, a clinician who knows the person is the one who can say what a result or a choice means for them.
Questions
- Does brain training prevent dementia?
- The studies cited here measured cognitive test scores, not dementia diagnoses. A Cochrane review of eight RCTs with 1183 participants found slight improvement in global cognitive function at 12 weeks, with low or very low quality evidence.
- Do omega-3 supplements lower the risk of dementia?
- Observational data suggest a lower risk: a meta-analysis of 48 longitudinal studies found dietary omega-3 intake could lower risk of all-cause dementia or cognitive decline by about 20%. A randomized trial of DHA in people with mild to moderate Alzheimer's did not slow decline.
- Do vitamins or supplements improve memory in mild cognitive impairment?
- A review of 20 reviews found most were limited by quality and small studies, and concluded that few nutritional interventions convincingly improve cognition in MCI.
Read on
- Prevention
- Diet and Alzheimer's: the studies
- Exercise and dementia: the studies
- Risk factors
- All answer pages
Related questions
Last updated